Published on November 9, 2009 at 1:21 AM
Echosens, the French high-technology company specializing in non-invasive diagnostics in hepatology is the official sponsor of the Symposium held by Pr Sarin in the Famous Institute of liver and Biliary Sciences of New Delhi today. This symposium will focus on the non invasive diagnosis and management of hepatic fibrosis, with speakers from all around the world.
FibroScan®, an efficient and non-invasive diagnostic technique
The Fibroscan® powered by VCTETM gives a unique capability to physician. This device specific to the liver, measures in a quantitative and reproducible way the "degree of hepatic fibrosis", from children to adults, of all shapes and sizes. With immediate result this non-invasive diagnostic method is a real revolution for liver diseases management, a revolution that Indian patients will be able to benefit from now.
Echosens will support the Indian market for the FibroScan®, a product commercially available since 2005 worldwide and selected by the community of hepatologists thanks to more than 250 independent publications. Fibroscan® is the first clinically validated device using Elastography. According to Richard Guillaume, CEO of Echosens, "With its non-invasive nature, its ease of use and its immediate results, FibroScan® has already revolutionized the medical practice of hepatologists in Europe and Asia, and is expected to experience the same success in India."
http://www.echosens.com/